BioCentury
ARTICLE | Company News

Scios Nova Inc. deal

October 3, 1994 7:00 AM UTC

FGF stimulates blood vessel formation and other tissue repair processes.

Kaken will make undislosed payments to the Mountain View, Calif., company for the supply of material, the process development collaboration, and the license to SCIO's bFGF manufacturing technology. The payments are in addition to those provided for in the 1988 agreement. ...